MPACH News
Featured Story
Researchers find GLP-1 RA Prescriptions Skyrocketed From 2018 to 2023
A class of medications developed and commonly used to treat diabetes and weight management, glucagon-like peptide 1 receptor agonists (GLP-1 RAs), rose in prescribing trends significantly from 2018 to 2023.
- Alexandra Willis earns national recognition at AUPHA annual conference
- UTHealth Houston Fleming Center Launches Inaugural Executive Certificate in Healthcare Management & Leadership with Student-Led Innovation Showcase
- Catherine Troisi elected Chair-Elect of the International Network of Epidemiology in Policy
- Innovation in Action: 15th Annual Fleming Center Case Competition
- Driving Innovation Virtually: Virtual Fleming Center Case Competition
- From Policy to Pantry: Robinson Champions Community Health
- New Study Finds Viewing Political TikTok Influencers Can Increase Negative Emotional Affect in Young Adults
- ACHE of the Southwest: A New Era of Leadership and Growth